Treco Douglas A
CEO & Chairman at Inozyme Pharma, Inc.
- Sold, on record
- $60k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Apr 2, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Inozyme Pharma, Inc.CEO & Chairman
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Inozyme Pharma, Inc.UnusualApr 2, 2024 2024
Sold 7,523 shares at $6.94 ($52k)
Treco Douglas A, CEO
No 10b5-1 planSold 26.7% of holdings ($196k position)20,665 shares leftFirst sale on recordFiling
- 2 Form 4 sale Inozyme Pharma, Inc.No planApr 2, 2025 +365 days
Sold 8,819 shares at $0.89 ($8k)
Treco Douglas A, CEO & Chairman
No 10b5-1 planSold 17.7% of holdings ($44k position)41,046 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2025 | Apr 3, 2025 | Inozyme Pharma, Inc. | CEO & Chairman | Form 4 sale | 8,819 | $8k | 17.7% | No plan | SEC |
| Apr 2, 2024 | Apr 3, 2024 | Inozyme Pharma, Inc. | CEO | Form 4 sale | 7,523 | $52k | 26.7% | Unusual | SEC |